Efficacy of Prophylactic Anti-VEGF in Preventing Radiation Retinopathy: A Systematic Review and Meta-Analysis.

Andi Arus VictorGitalisa AndayaniAri DjatikusumoAnggun Rama YudanthaMario Marbungaran HutapeaTriana Hardianti GunardiHannah Soetjoadi

Published in: Clinical ophthalmology (Auckland, N.Z.) (2023)

Prophylactic anti-VEGF therapy might delay RM and RON, preventing high-risk patients from developing poor VA by approximately 50%. However, this evidence should be interpreted with caution because of its low level of certainty. Future robust studies are warranted to confirm this finding.

Keyphrases

end stage renal disease
vascular endothelial growth factor
endothelial cells
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
cell therapy